Olive Healthcare establishes and commences activity at yet another Manufacturing Site (Unit #3) in India. This Facility is dedicated only for Exports to the Regulated / Advanced Market. Facility undergoes a US- FDA inspection in September 2012.
Change in strategy gear up towards International Regulatory Approvals. Olive Healthcare facility undergoes major structure and technical modifications.
Olive Healthcare establishes another WHO GMP compliant Facility under the banner Olive Softgel. This facility takes care of the entire local Soft Gel Demand hence making Olive Healthcare a completely Export Oriented Unit.
Construction of the second WHO GMP approved Manufacturing unit under the Banner Olive Healthcare.
Construction of the First WHO GMP approved manufacturing unit under the name Savita Pharmaceutical (P) LTD.
Company undergoes change in Management. Company operational under the same banner of Gelsules Medicap (P) Ltd.
Soft Gel Manufacturing commences under the name Gelsules Medicaps ltd.